Strides Shasun to acquire controlling stake in Universal Corporation, Kenya

09 Feb 2016 Evaluate

Strides Shasun has signed definitive agreements to acquire a controlling stake in Universal Corporation, Kenya. The transaction is subject to statutory approvals and customary closing conditions and expected to be close by 30 June 2016.  With this acquisition, the company will get a strong presence in the key east African markets and will complement its current capacities of six strategically located plants across major geographies in Sub Saharan Africa.

Under the terms of the agreement, the company will hold 51% of the issued capital of Universal and the remaining 49% will continue to hold by the current promoters. This is an all-cash deal & the total consideration will consist of initial pay out of $11 million and a performance related earn out capped at $ 3 million for achieving an EBITDA of $ 2.95 million for 2015. The acquisition will be made through Strides Pharma (Cyprus), a wholly owned subsidiary of the company.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

825.35 -34.95 (-4.06%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×